Research Update

Brexpiprazole Ineffective in Mania

Topics: Brexpiprazole | Mania | Mood Stabilizers | Psychopharm Myths | Psychopharmacology | Research Update

REVIEW OF: Vieta E et al, J Psychopharmacol 2021;35(8):971–982 TYPE OF STUDY: Phase III randomized controlled trials Brexpiprazole is FDA approved in schizophrenia and as an adjunct for major depression and is one of the better-tolerated antipsychotics. Like aripiprazole, it is a partial D2 and 5-HT1A agonist. Unlike most antipsychotics, brexpiprazo

Read More